Persium Advisors LLC purchased a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 3,697 shares of the financial services provider’s stock, valued at approximately $686,000.
A number of other institutional investors also recently made changes to their positions in the stock. Hanson & Doremus Investment Management lifted its stake in shares of Marsh & McLennan Companies by 31.3% in the 3rd quarter. Hanson & Doremus Investment Management now owns 214 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 51 shares during the period. D.A. Davidson & CO. lifted its stake in shares of Marsh & McLennan Companies by 1.2% in the 3rd quarter. D.A. Davidson & CO. now owns 4,514 shares of the financial services provider’s stock worth $910,000 after acquiring an additional 54 shares during the period. Procyon Advisors LLC lifted its stake in shares of Marsh & McLennan Companies by 2.5% in the 4th quarter. Procyon Advisors LLC now owns 2,279 shares of the financial services provider’s stock worth $423,000 after acquiring an additional 56 shares during the period. Lindenwold Advisors INC lifted its stake in shares of Marsh & McLennan Companies by 0.4% in the 3rd quarter. Lindenwold Advisors INC now owns 14,994 shares of the financial services provider’s stock worth $3,022,000 after acquiring an additional 62 shares during the period. Finally, Ashton Thomas Securities LLC lifted its stake in shares of Marsh & McLennan Companies by 1.8% in the 3rd quarter. Ashton Thomas Securities LLC now owns 3,663 shares of the financial services provider’s stock worth $736,000 after acquiring an additional 63 shares during the period. 87.99% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on MRSH. JPMorgan Chase & Co. reduced their price target on shares of Marsh & McLennan Companies from $242.00 to $226.00 and set an “overweight” rating for the company in a research note on Wednesday, January 7th. Morgan Stanley cut their target price on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research note on Monday. Raymond James Financial raised shares of Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price for the company in a research note on Tuesday, February 17th. Keefe, Bruyette & Woods increased their target price on shares of Marsh & McLennan Companies from $205.00 to $206.00 and gave the company a “market perform” rating in a research note on Monday, February 2nd. Finally, Citigroup increased their target price on shares of Marsh & McLennan Companies from $201.00 to $205.00 and gave the company a “neutral” rating in a research note on Tuesday, February 3rd. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $211.75.
Marsh & McLennan Companies Stock Performance
Shares of NYSE:MRSH opened at $174.98 on Tuesday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 1.20. The stock has a market cap of $84.71 billion, a P/E ratio of 20.76, a PEG ratio of 2.38 and a beta of 0.75. Marsh & McLennan Companies, Inc. has a 52 week low of $164.89 and a 52 week high of $239.34. The company has a 50 day moving average price of $175.26.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its quarterly earnings data on Thursday, January 29th. The financial services provider reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.97 by $0.15. Marsh & McLennan Companies had a net margin of 15.42% and a return on equity of 31.60%. The firm had revenue of $6.60 billion for the quarter, compared to analyst estimates of $6.52 billion. During the same quarter in the prior year, the business earned $1.87 EPS. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, equities analysts predict that Marsh & McLennan Companies, Inc. will post 9.61 earnings per share for the current year.
Marsh & McLennan Companies Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Thursday, April 9th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Thursday, April 9th. Marsh & McLennan Companies’s dividend payout ratio is currently 42.70%.
Insiders Place Their Bets
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $21,411,456.30. This represents a 12.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.35% of the stock is currently owned by company insiders.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
